Literature DB >> 32746065

Classifying Major Depressive Disorder and Response to Deep Brain Stimulation Over Time by Analyzing Facial Expressions.

Zifan Jiang, Sahar Harati, Andrea Crowell, Helen S Mayberg, Shamim Nemati, Gari D Clifford.   

Abstract

OBJECTIVE: Major depressive disorder (MDD) is a common psychiatric disorder that leads to persistent changes in mood and interest among other signs and symptoms. We hypothesized that convolutional neural network (CNN) based automated facial expression recognition, pre-trained on an enormous auxiliary public dataset, could provide improve generalizable approach to MDD automatic assessment from videos, and classify remission or response to treatment.
METHODS: We evaluated a novel deep neural network framework on 365 video interviews (88 hours) from a cohort of 12 depressed patients before and after deep brain stimulation (DBS) treatment. Seven basic emotions were extracted with a Regional CNN detector and an Imagenet pre-trained CNN, both of which were trained on large-scale public datasets (comprising over a million images). Facial action units were also extracted with the Openface toolbox. Statistics of the temporal evolution of these image features over each recording were extracted and used to classify MDD remission and response to DBS treatment.
RESULTS: An Area Under the Curve of 0.72 was achieved using leave-one-subject-out cross-validation for remission classification and 0.75 for response to treatment.
CONCLUSION: This work demonstrates the potential for the classification of MDD remission and response to DBS treatment from passively acquired video captured during unstructured, unscripted psychiatric interviews. SIGNIFICANCE: This novel MDD evaluation could be used to augment current psychiatric evaluations and allow automatic, low-cost, frequent use when an expert isn't readily available or the patient is unwilling or unable to engage. Potentially, the framework may also be applied to other psychiatric disorders.

Entities:  

Mesh:

Year:  2021        PMID: 32746065      PMCID: PMC7891869          DOI: 10.1109/TBME.2020.3010472

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  17 in total

Review 1.  Major depressive disorder.

Authors:  R H Belmaker; Galila Agam
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

Review 2.  Repetitive transcranial magnetic stimulation for major depressive disorder: a review.

Authors:  Z Jeff Daskalakis; Andrea J Levinson; Paul B Fitzgerald
Journal:  Can J Psychiatry       Date:  2008-09       Impact factor: 4.356

3.  Video-based detection of the clinical depression in adolescents.

Authors:  Namunu C Maddage; Rajinda Senaratne; Lu-Shih Alex Low; Margaret Lech; Nicholas Allen
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

4.  Classifying Depression Severity in Recovery From Major Depressive Disorder via Dynamic Facial Features.

Authors:  Sahar Harati; Andrea Crowell; Yijian Huang; Helen Mayberg; Shamim Nemati
Journal:  IEEE J Biomed Health Inform       Date:  2019-07-23       Impact factor: 5.772

5.  Emotion context insensitivity in major depressive disorder.

Authors:  Jonathan Rottenberg; James J Gross; Ian H Gotlib
Journal:  J Abnorm Psychol       Date:  2005-11

6.  Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.

Authors:  Mustafa M Husain; A John Rush; Max Fink; Rebecca Knapp; Georgios Petrides; Teresa Rummans; Melanie M Biggs; Kevin O'Connor; Keith Rasmussen; Marc Litle; Wenle Zhao; Hilary J Bernstein; Glenn Smith; Martina Mueller; Shawn M McClintock; Samuel H Bailine; Charles H Kellner
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

7.  A meta-analysis of emotional reactivity in major depressive disorder.

Authors:  Lauren M Bylsma; Bethany H Morris; Jonathan Rottenberg
Journal:  Clin Psychol Rev       Date:  2007-10-11

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  The PHQ-8 as a measure of current depression in the general population.

Authors:  Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad
Journal:  J Affect Disord       Date:  2008-08-27       Impact factor: 4.839

10.  Characterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective.

Authors:  Andrea L Crowell; Steven J Garlow; Patricio Riva-Posse; Helen S Mayberg
Journal:  Front Integr Neurosci       Date:  2015-06-15
View more
  5 in total

1.  A Personalized Spatial-Temporal Cold Pain Intensity Estimation Model Based on Facial Expression.

Authors:  Yikang Guo; Li Wang; Yan Xiao; Yingzi Lin
Journal:  IEEE J Transl Eng Health Med       Date:  2021-09-30       Impact factor: 3.316

2.  Deep Brain Stimulation for Depression.

Authors:  Martijn Figee; Patricio Riva-Posse; Ki Sueng Choi; Lucia Bederson; Helen S Mayberg; Brian H Kopell
Journal:  Neurotherapeutics       Date:  2022-07-11       Impact factor: 6.088

3.  Utilizing computer vision for facial behavior analysis in schizophrenia studies: A systematic review.

Authors:  Zifan Jiang; Mark Luskus; Salman Seyedi; Emily L Griner; Ali Bahrami Rad; Gari D Clifford; Mina Boazak; Robert O Cotes
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

4.  Multimodal Assessment of Schizophrenia and Depression Utilizing Video, Acoustic, Locomotor, Electroencephalographic, and Heart Rate Technology: Protocol for an Observational Study.

Authors:  Robert O Cotes; Mina Boazak; Emily Griner; Zifan Jiang; Bona Kim; Whitney Bremer; Salman Seyedi; Ali Bahrami Rad; Gari D Clifford
Journal:  JMIR Res Protoc       Date:  2022-07-13

5.  Automated analysis of facial emotions in subjects with cognitive impairment.

Authors:  Zifan Jiang; Salman Seyedi; Rafi U Haque; Alvince L Pongos; Kayci L Vickers; Cecelia M Manzanares; James J Lah; Allan I Levey; Gari D Clifford
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.